HighQC™ Human IPSC-Derived Neural Stem Cell MAPT V337M HET

Human Human IPSC-Derived Neural Stem Cells that have been genetically edited using CRISPR-Cas9 technology to introduce the V337M mutation (CGG>TGG) into the MAPT gene. This line is homozygous for the V337M mutation so both alleles contain the mutation.